Pablo Lorenzano Menna

Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma

D. Golombek, G. Cardama, P. Lorenzano Menna, 2021, Pharmaceutics.

Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment

Ezequiel I. Juritz, D. Gomez, R. Armando, 2018, International journal of molecular sciences.

New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis

A. F. Castillo, D. Gomez, P. Maloberti, 2020, Cellular and Molecular Life Sciences.